{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T04:17:18Z","timestamp":1777004238404,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,8]]},"DOI":"10.7759\/cureus.46692","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T08:41:38Z","timestamp":1696840898000},"source":"Crossref","is-referenced-by-count":2,"title":["Daptomycin-Induced Acute Liver Failure: A Rare Case Report"],"prefix":"10.7759","author":[{"given":"Medha","family":"Rajamanuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julton","family":"Tomanguillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Ayoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadeem","family":"Anwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","author":"Wendon","year":"2017","unstructured":"Wendon, J, Cordoba J, Dhawan A, et al.. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017, 66:1047-81. 10.1016\/j.jhep.2016.12.003","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17020224","article-title":"Hepatotoxicity by drugs: the most common implicated agents","volume":"17","author":"Bj\u00f6rnsson ES","year":"2016","unstructured":"Bj\u00f6rnsson ES. Hepatotoxicity by drugs: the most common implicated agents. Int J Mol Sci. 2016, 17:224. 10.3390\/ijms17020224","journal-title":"Int J Mol Sci"},{"key":"ref3","article-title":"Acetaminophen","year":"2016","unstructured":"Acetaminophen. LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2016."},{"key":"ref4","article-title":"Daptomycin","year":"2016","unstructured":"Daptomycin. LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2016."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8553(21)00066-2","article-title":"Liver transplantation for fulminant hepatic failure","volume":"22","author":"Lidofsky SD","year":"1993","unstructured":"Lidofsky SD. Liver transplantation for fulminant hepatic failure. Gastroenterol Clin North Am. 1993, 22:257-69. 10.1016\/S0889-8553(21)00066-2","journal-title":"Gastroenterol Clin North Am"},{"key":"ref6","article-title":"Adverse drug reaction probability scale (Naranjo) in drug induced liver injury","year":"2019","unstructured":"Adverse drug reaction probability scale (Naranjo) in drug induced liver injury. LiverTox. Clinical and Research Information on Drug-Induced Liver Injury. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda; 2019."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo CA","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al.. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30:239-45. 10.1038\/clpt.1981.154","journal-title":"Clin Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.idcr.2018.e00452","article-title":"A case report and literature review of daptomycin-induced liver injury","volume":"14","author":"Janda A","year":"2018","unstructured":"Janda A, Jogendra MR. A case report and literature review of daptomycin-induced liver injury. IDCases. 2018, 14:e00452. 10.1016\/j.idcr.2018.e00452","journal-title":"IDCases"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03157-14","article-title":"Case report and cohort analysis of drug-induced liver injury associated with daptomycin","volume":"58","author":"Bohm N","year":"2014","unstructured":"Bohm N, Makowski C, Machado M, et al.. Case report and cohort analysis of drug-induced liver injury associated with daptomycin. Antimicrob Agents Chemother. 2014, 58:4902-3. 10.1128\/AAC.03157-14","journal-title":"Antimicrob Agents Chemother"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1K579","article-title":"Daptomycin-induced acute renal and hepatic toxicity without rhabdomyolysis","volume":"42","author":"Abraham G","year":"2008","unstructured":"Abraham G, Finkelberg D, Spooner LM. Daptomycin-induced acute renal and hepatic toxicity without rhabdomyolysis. Ann Pharmacother. 2008, 42:719-21. 10.1345\/aph.1K579","journal-title":"Ann Pharmacother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/180811-daptomycin-induced-acute-liver-failure-a-rare-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:24Z","timestamp":1707508464000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/180811-daptomycin-induced-acute-liver-failure-a-rare-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,8]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.46692","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,8]]}}}